SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper

Produktnummer ABIN6952544

Hersteller Produkt- Nr.: 200-401-a50

Produktdetails

Highlights:

• Detection of SARS-CoV-2 with variety of different immunoassays, i.e. ELISA, Lateral Flow, as validated by numerous publications (see below).
• Nucleocapsid antibody used for diagnostic Covid19 testing as well as for drug discovery.
• Developed and manufactured in the U.S.

Target: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Reaktivität: SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: ELISA, Western Blotting (WB), Flow Cytometry (FACS), Fluorescence Microscopy (FM), Immunohistochemistry (IHC)

Hersteller Produkt- Nr.: 200-401-a50

Hersteller: Rockland

Verwendungszweck: Sars Nucleocapsid Protein Antibody

Spezifität: Detects the Nucleocapsid (N), Omicron, and BA.2 sub-variant.

Kreuzreaktivität (Details): This protein A purified antibody is directed against SARS Coronavirus Nucleocapsid (N) protein

Homologie: Predicted reactivity based on immunogen sequence: SARS-CoV2 Nucleocapsid protein: (homology 90%)

Aufreinigung: .The product was purified from monospecific antiserum by protein A affinity purification.

Immunogen: This protein A purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a purified recombinant protein corresponding to full length SARS Coronavirus Nucleocapsid protein. Lifesensors Inc. (www.lifesensors.com) prepared the Nucleocapsid protein as follows: SUMO-Nucleocapsid fusion was expressed in E.coli in LB medium and purified using Ni-NTA resin (Qiagen) affinity chromatography. After the fusion was cleaved by the SUMO Protease (LifeSensors), the SUMO tag and protease were subtracted from the nucleocapsid using MAC and the nucleocapsid was finally purified using Cation Exchange Chromatography with the Macro-Prep High S resin (BioRad) and size exclusion chromatography.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

ELISA_Dilution: 1:10,000 - 1:50,000

Immunohistochemistry_Dilution: 1:100-1:6000

Flow_Cytometry_Dilution: User Optimized

IF_Microscopy_Dilution: User Optimized

Western_Blot_Dilution: 1:2,000 - 1:10,000

Kommentare:

Suggested Applications: FC, FISH, IF, IHC, LFA, Multiplex, Other
This protein A purified antibody has been tested for use in ELISA, western blot, Immunohistochemistry, Immunofluorescence, and lateral flow.  Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 46 kDa in size corresponding to SARS Nucleocapsid (N) protein by western blotting in the appropriate cell lysate or extract. ELISA and lateral flow format has been used to detect virus in extracts from nasal and throat swabs and saliva. IF has been used to determine the presence or absence of virus entering cells especially when anti-viral drugs are applied. IHC studies have been performed on biopsies, included retrospective studies on cadaver tissues after formalin fixation and paraffin embedding, detecting the coronavirus in lung, liver, bile duct, and placenta tissue. Yet other studies have shown this antibody has the ability to neutralize the virus and thereby protect cells from the uptake of live virus. Others have demonstrated the utility of the antibody in flow cytometry studies.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution:

Reconstitution_Buffer: Restore with deionized water (or equivalent)

Reconstitution_Volume: 100 μL

Buffer:

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

Stabilizer: None

Preservative: 0.01 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store vial at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

Haltbarkeit: 12 months

Referenzen

Du, Deiter, Bouzidi, Billaud, Simmons, Dabral, Selvarajah, Lingappa, Michon, Yu, Paulvannan, Manicassamy, Lingappa, Boushey, Greenland, Pillai: "A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells." in: Communications biology, Vol. 7, Issue 1, pp. 486, (2024) (PubMed).

Weingarten-Gabbay, Chen, Sarkizova, Taylor, Gentili, Hernandez, Pearlman, Bauer, Rice, Clauser, Hacohen, Carr, Abelin, Saeed, Sabeti: "The HLA-II immunopeptidome of SARS-CoV-2." in: Cell reports, Vol. 43, Issue 1, pp. 113596, (2024) (PubMed).

Brogna, Bisaccia, Costanzo, Lettieri, Montano, Viduto, Fabrowski, Cristoni, Prisco, Piscopo: "Who Is the Intermediate Host of RNA Viruses? A Study Focusing on SARS-CoV-2 and Poliovirus." in: Microorganisms, Vol. 12, Issue 4, (2024) (PubMed).

Gallucci, Bazire, Davidson, Shytaj: "Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro." in: Antiviral research, Vol. 221, pp. 105766, (2024) (PubMed).

Bagato, Balkema-Buschmann, Todt, Weber, Gömer, Qu, Miskey, Ivics, Mettenleiter, Finke, Brown, Breithaupt, Ushakov: "Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs." in: Microbiology spectrum, Vol. 12, Issue 1, pp. e0246923, (2024) (PubMed).

Barlang, Deimel, Mohl, Blaurock, Balkema-Buschmann, Weinbender, Hess, Obernolte, Merkel, Popp: "Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs." in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 196, pp. 106744, (2024) (PubMed).

Datta, Chen, Tavares, Reyes-Robles, Ryu, Khan, Bechtel, Bertoch, White, Hazuda, Vora, Hett, Fadeyi, Oslund, Emili, Saeed: "High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface." in: Cell chemical biology, Vol. 30, Issue 10, pp. 1313-1322.e7, (2023) (PubMed).

Stüdle, Nishihara, Wischnewski, Kulsvehagen, Perriot, Ishikawa, Schroten, Frank, Deigendesch, Du Pasquier, Schirmer, Pröbstel, Engelhardt: "SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier." in: Fluids and barriers of the CNS, Vol. 20, Issue 1, pp. 76, (2023) (PubMed).

Vanderlinden, Boonen, Noppen, Schoofs, Imbrechts, Geukens, Snoeck, Stevaert, Naesens, Andrei, Schols: "PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding." in: Antiviral research, Vol. 217, pp. 105700, (2023) (PubMed).

Huang, Fan, Sun, Yang, Zhang, Wang, Li, Zhang, Zhang, Li, Wang, Feng, Zhao, Chen, Qu: "SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril." in: Antiviral research, Vol. 215, pp. 105636, (2023) (PubMed).

Koutsakos, Reynaldi, Lee, Nguyen, Amarasena, Taiaroa, Kinsella, Liew, Tran, Kent, Tan, Rowntree, Nguyen, Thomas, Kedzierska, Petersen, Rossjohn, Williamson, Khoury, Davenport, Kent, Wheatley, Juno: "SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses." in: Immunity, Vol. 56, Issue 4, pp. 879-892.e4, (2023) (PubMed).

Mäkelä, Uğurlu, Hannula, Kant, Salminen, Fagerlund, Mäki, Haveri, Strandin, Kareinen, Hepojoki, Kuivanen, Levanov, Pasternack, Naves, Ritvos, Österlund, Sironen, Vapalahti, Kipar, Huiskonen, Rissanen, Saksela: "Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants." in: Nature communications, Vol. 14, Issue 1, pp. 1637, (2023) (PubMed).

Chen, Chin, Kenney, Tavares, Khan, Conway, Liu, Choudhary, Gertje, O'Connell, Adams, Kotton, Herrmann, Ensser, Connor, Bosmann, Li, Gack, Baker, Kirchdoerfer, Kataria, Crossland, Douam, Saeed: "Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation." in: Nature, Vol. 615, Issue 7950, pp. 143-150, (2023) (PubMed).

Brogna, Costanzo, Brogna, Bisaccia, Brogna, Giuliano, Montano, Viduto, Cristoni, Fabrowski, Piscopo: "Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification." in: International journal of molecular sciences, Vol. 24, Issue 4, (2023) (PubMed).

Tang, Buchholz, Szigety, Imbiakha, Gao, Frankfurter, Wang, Yang, Hewins, Mericko-Ishizuka, Leu, Sterling, Monreal, Sahler, August, Zhu, Jurado, Xu, Morrisey, Millar, Aguilar, Kahn: "Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection." in: PLoS biology, Vol. 21, Issue 2, pp. e3001989, (2023) (PubMed).

Chen, Turcinovic, Feng, Kenney, Chin, Choudhary, Conway, Semaan, Close, Tavares, Seitz, Khan, Kapell, Crossland, Li, Douam, Baker, Connor, Saeed: "Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus." in: iScience, Vol. 26, Issue 5, pp. 106634, (2023) (PubMed).

Swain, Merida, Rubio, Bracquemond, Neyret, Aguilar-Ordoñez, Günther, Barreto, Muriaux: "F-actin nanostructures rearrangements and regulation are essential for SARS-CoV-2 particle production in host pulmonary cells." in: iScience, Vol. 26, Issue 8, pp. 107384, (2023) (PubMed).

Lin, Chen, Scartelli, Xie, Merrill-Skoloff, Yang, Sun, Saeed, Flaumenhaft: "Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication." in: iScience, Vol. 26, Issue 9, pp. 107602, (2023) (PubMed).

Fraternale, De Angelis, De Santis, Amatore, Masini, Monittola, Menotta, Biancucci, Bartoccini, Retini, Fiori, Fioravanti, Magurano, Chiarantini, Lista, Piersanti, Palamara, Nencioni, Magnani, Crinelli: "Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 37, Issue 2, pp. e22741, (2023) (PubMed).

Gao, Tang, Wang, Buchholz, Imbiakha, Yang, Chen, Hewins, Mericko-Ishizuka, Leu, Sterling, August, Jurado, Morrisey, Aguilar-Carreno, Kahn: "Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in mice." in: Frontiers in cardiovascular medicine, Vol. 10, pp. 1266276, (2023) (PubMed).

Antigendetails

Target: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Andere Bezeichnung: Sars Nucleocapsid Protein (SARS-CoV N Produkte)

Substanzklasse: Viral Protein

Hintergrund: The coronavirus nucleocapsid protein is the major structural component of virions that associates with genomic RNA to form a long, flexible, helical nucleocapsid. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three-domain structure for the nucleocapsid protein.
Synonyms: N antibody, N structural protein antibody, NC antibody, Nucleocapsid protein antibody, Nucleoprotein antibody, SARS coronavirus N protein antibody, SARS CoV antibody, SARSCoV antibody, Severe acute respiratory syndrome antibody

Gen-ID: 1489678, 30173007

UniProt: P59595